StrideBio has a total of 93 patents globally, out of which no patents have been granted. Of these 93 patents, more than 91% patents are active. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of StrideBio. StrideBio was founded in 2015. StrideBio
Embrex has a total of 243 patents globally, out of which 95 have been granted. Of these 243 patents, more than 10% patents are active. Mexico, Europe is where Embrex has filed the maximum number of patents, followed by Brazil and Austria. Parallelly, USA seems to be the main focused
Emergo Therapeutics has a total of 29 patents globally, out of which 7 have been granted. Of these 29 patents, more than 75% patents are active. The United States of America is where Emergo Therapeutics has filed the maximum number of patents, followed by Europe (EPO), Australia, Canada and Japan.
Bioviva has a total of 11 patents globally, out of which 1 have been granted. Of these 11 patents, more than 54% patents are active. The United States of America is where Bioviva has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to
Dalan Animal Health has a total of 26 patents globally, out of which 2 have been granted. Of these 26 patents, more than 88% patents are active. Europe is where Dalan Animal Health has filed the maximum number of patents, followed by United States of America. Parallelly, United States of
Karius has a total of 87 patents globally, out of which 29 have been granted. Of these 87 patents, more than 73% patents are active. United States of America is where Karius has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems
Invetx has a total of 57 patents globally, out of which 5 have been granted. Of these 57 patents, more than 92% patents are active. United States of America is where Invetx has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and Australia. Parallelly, United States of
Ibex Biosciences has a total of 36 patents globally, out of which 1 has been granted. Of these 36 patents, more than 88% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Ibex Biosciences. Ibex Biosciences
Centivax has a total of 31 patents globally, out of which 10 have been granted. Of these 31 patents, more than 67% patents are active. The United States of America is where Centivax has filed the maximum number of patents, followed by Europe and Hong Kong (S.A.R.). Parallelly, United States
Aulos Bioscience has a total of 18 patents globally, out of which 4 have been granted. Of these 18 patents, more than 59% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Aulos Bioscience. Aulos Bioscience
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.